PIGX expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.081200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.411800E-01
Normal-vs-Stage2
4.480800E-01
Normal-vs-Stage3
8.976600E-01
Normal-vs-Stage4
4.807400E-01
Stage1-vs-Stage2
4.408200E-01
Stage1-vs-Stage3
2.173200E-01
Stage1-vs-Stage4
9.214800E-01
Stage2-vs-Stage3
4.796000E-01
Stage2-vs-Stage4
6.227400E-01
Stage3-vs-Stage4
4.578800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.487600E-01
Normal-vs-AfricanAmerican
2.704600E-01
Normal-vs-Asian
3.878000E-01
Caucasian-vs-AfricanAmerican
3.028400E-01
Caucasian-vs-Asian
8.781400E-01
AfricanAmerican-vs-Asian
4.237400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.754800E-01
Normal-vs-Female
3.327600E-01
Male-vs-Female
7.512400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.246600E-01
Normal-vs-Age(41-60Yrs)
2.192800E-01
Normal-vs-Age(61-80Yrs)
5.637000E-01
Normal-vs-Age(81-100Yrs)
4.042600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.20400000000054E-05
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.360200E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.967400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.322900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.559500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.682400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.222600E-01
Normal-vs-Daily Drinker
8.000800E-01
Normal-vs-Weekly Drinker
3.466400E-01
Normal-vs-Occasional Drinker
3.403400E-01
Normal-vs-Social Drinker
3.284400E-01
Non Drinker-vs-Daily Drinker
7.619600E-01
Non Drinker-vs-Weekly Drinker
3.412200E-01
Non Drinker-vs-Occasional Drinker
6.715700E-02
Non Drinker-vs-Social Drinker
1.525370E-01
Daily Drinker-vs-Weekly Drinker
1.935190E-01
Daily Drinker-vs-Occasional Drinker
4.946400E-02
Daily Drinker-vs-Social Drinker
8.941600E-02
Weekly Drinker-vs-Occasional Drinker
1.846190E-01
Weekly Drinker-vs-Social Drinker
6.062000E-01
Occasional Drinker-vs-Social Drinker
3.377400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.938600E-01
Normal-vs-Grade 2
1.367830E-01
Normal-vs-Grade 3
1.016560E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.672600E-01
Grade 1-vs-Grade 3
4.890600E-01
Grade 1-vs-Grade 4
2.938600E-01
Grade 2-vs-Grade 3
9.869000E-01
Grade 2-vs-Grade 4
1.367830E-01
Grade 3-vs-Grade 4
1.016560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.140800E-01
Normal-vs-NonDiabetic
3.918000E-01
Diabetic-vs-NonDiabetic
2.295600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.382200E-01
Normal-vs-NoPancreatitis
4.556600E-01
Pancreatitis-vs-NoPancreatitis
7.760400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.287400E-01
Normal-vs-N1
4.455600E-01
N0-vs-N1
5.908400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.271000E-01
Normal-vs-TP53-NonMutant
2.930600E-01
TP53-Mutant-vs-TP53-NonMutant
3.422600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
